(Q45349920)

English

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.

scientific article published on 24 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T Lodewyck

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

M Oudshoorn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

E Petersen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

P A von dem Borne

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

A Schattenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

W Allebes

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

M Groenendijk-Sijnke

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

L Duinhouwer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

R Willemze

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

B Lowenberg

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

L F Verdonck

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

E Meijer

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

J J Cornelissen

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

24 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1548-1554

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21606965%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

https://scigraph.springernature.com/pub.10.1038/leu.2011.123

0 references

Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Graft-versus-disease effect following allogeneic transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Optimal management of adults with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

A scheme for defining cause of death and its application in the T cell depletion trial.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

21 January 2018

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Limits of HLA mismatching in unrelated hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.123

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45349920&oldid=2134021975"